Porsche Automobil Holding Valuation
Is PAH3 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of PAH3 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: PAH3 (€33.93) is trading below our estimate of fair value (€61.2)
Significantly Below Fair Value: PAH3 is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for PAH3?
Key metric: As PAH3 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is PAH3's PE Ratio? | |
|---|---|
| PE Ratio | 2.8x |
| Earnings | €3.80b |
| Market Cap | €10.58b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | n/a |
| Enterprise Value/EBITDA | 83.1x |
| PEG Ratio | 0.2x |
Price to Earnings Ratio vs Peers
How does PAH3's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 39.9x | ||
RNO Renault | 7.7x | 26.5% | €10.7b |
7270 Subaru | 4.6x | -3.3% | JP¥1.8t |
600418 Anhui Jianghuai Automobile GroupLtd | 137x | 29.6% | CN¥85.0b |
FROTO Ford Otomotiv Sanayi | 10.4x | 40.5% | ₺348.5b |
PAH3 Porsche Automobil Holding | 2.8x | 18.5% | €10.6b |
Price-To-Earnings vs Peers: PAH3 is good value based on its Price-To-Earnings Ratio (2.8x) compared to the peer average (39.9x).
Price to Earnings Ratio vs Industry
How does PAH3's PE Ratio compare vs other companies in the Global Auto Industry?
| 1 Company | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 1 Company | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: PAH3 is good value based on its Price-To-Earnings Ratio (2.8x) compared to the Global Auto industry average (15.6x).
Price to Earnings Ratio vs Fair Ratio
What is PAH3's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 2.8x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate PAH3's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €33.93 | €47.09 +38.8% | 26.7% | €70.00 | €26.00 | n/a | 11 |
| Nov ’25 | €40.49 | €49.20 +21.5% | 22.7% | €70.00 | €35.00 | n/a | 10 |
| Oct ’25 | n/a | €51.77 0% | 19.2% | €70.00 | €36.00 | n/a | 11 |
| Sep ’25 | n/a | €56.50 0% | 28.2% | €97.00 | €36.00 | n/a | 11 |
| Aug ’25 | n/a | €58.70 0% | 27.1% | €97.00 | €35.00 | n/a | 10 |
| Jul ’25 | n/a | €60.40 0% | 23.5% | €97.00 | €45.00 | n/a | 10 |
| Jun ’25 | €50.34 | €60.40 +20.0% | 23.5% | €97.00 | €45.00 | n/a | 10 |
| May ’25 | €47.99 | €60.40 +25.9% | 23.5% | €97.00 | €45.00 | n/a | 10 |
| Apr ’25 | n/a | €62.64 0% | 25.2% | €97.00 | €45.00 | n/a | 11 |
| Mar ’25 | n/a | €63.55 0% | 29.6% | €104.00 | €47.00 | n/a | 11 |
| Feb ’25 | €45.77 | €65.25 +42.6% | 26.8% | €104.00 | €47.00 | n/a | 12 |
| Jan ’25 | n/a | €66.00 0% | 26.4% | €104.00 | €47.00 | n/a | 12 |
| Dec ’24 | n/a | €64.75 0% | 22.6% | €97.00 | €47.00 | n/a | 12 |
| Nov ’24 | €42.13 | €68.17 +61.8% | 22.8% | €102.00 | €47.00 | €40.49 | 12 |
| Oct ’24 | €45.63 | €68.17 +49.4% | 22.8% | €102.00 | €47.00 | n/a | 12 |
| Sep ’24 | €49.31 | €68.90 +39.7% | 22.8% | €102.00 | €47.00 | n/a | 12 |
| Aug ’24 | €53.46 | €71.90 +34.5% | 30.7% | €134.00 | €51.00 | n/a | 12 |
| Jul ’24 | €54.80 | €73.27 +33.7% | 31.1% | €134.00 | €51.00 | n/a | 11 |
| Jun ’24 | €54.40 | €73.50 +35.1% | 32.2% | €134.00 | €51.00 | €50.34 | 10 |
| May ’24 | €49.46 | €74.09 +49.8% | 30.5% | €134.00 | €51.00 | €47.99 | 11 |
| Apr ’24 | €52.32 | €75.08 +43.5% | 28.9% | €134.00 | €51.00 | n/a | 12 |
| Mar ’24 | €53.36 | €89.00 +66.8% | 29.0% | €134.00 | €60.00 | n/a | 12 |
| Feb ’24 | €55.18 | €89.00 +61.3% | 29.0% | €134.00 | €60.00 | €45.77 | 12 |
| Jan ’24 | n/a | €92.45 0% | 26.4% | €134.00 | €60.00 | n/a | 11 |
| Dec ’23 | €57.82 | €95.10 +64.5% | 25.3% | €134.00 | €60.00 | n/a | 10 |
| Nov ’23 | €57.00 | €94.70 +66.1% | 24.7% | €132.00 | €60.00 | €42.13 | 10 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.